MediClin Says Asklepios Boosts Holding, Gives Role to CEO

MediClin AG (MED) said Asklepios Kliniken GmbH increased its stake in the German company to 52.7 percent. The acquirer’s supervisory board appointed MediClin Chief Executive Officer Ulrich Wandschneider as chairman of corporate management of Asklepios, effective Nov. 1, MediClin said today in a statement.

To contact the editor responsible for this story: Nicholas Comfort at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.